Company / Working Capital
Nuvalent, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.3B
FY2025
5-year range
$281.8M / $1.3B
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
#35 of 213
Health Care
What the data says
Nuvalent, Inc.'s working capital of $1.3B is higher than 84% of companies in the Health Care sector (FY2025). Working Capital has increased for 5 consecutive years, from $6M in FY2020 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +190.7%. Top quartile in the Health Care sector.
Improved from $695M to $1.3B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +41.6%
- 5-Year CAGR
- +190.7%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 213This company $1.3B Sector average $934.6M
▼
+39.2% above sector average
Key checks
Key Insights
- Nuvalent, Inc.'s working capital has grown for 5 consecutive years.
- 5-year CAGR of +190.7%, indicating consistent growth.
- In FY2025, working capital increased 20.7% year-over-year.
- Ranks #35 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +20.7% |
| FY2024 | $1.1B | +55.2% |
| FY2023 | $694.7M | +51.5% |
| FY2022 | $458.5M | +62.7% |
| FY2021 | $281.8M | +4397.9% |
| FY2020 | $6.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026